Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
Abstract In current molecular medicine, next-generation sequencing (NGS) for transcript variant detection and multivariable analyses are valid methods for evaluating gene expression, cancer mechanisms, and prognoses of patients. We conducted RNA-sequencing on samples from patients with primary centr...
Main Authors: | Yasuo Takashima, Atsushi Kawaguchi, Ryuichi Sato, Kenichi Yoshida, Azusa Hayano, Jumpei Homma, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Shin Ishizawa, Hiroaki Hondoh, Masakazu Nakano, Seishi Ogawa, Kei Tashiro, Ryuya Yamanaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-019-46473-5 |
Similar Items
-
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
by: Yasuo Takashima, et al.
Published: (2019-01-01) -
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
by: Yasuo Takashima, et al.
Published: (2020-01-01) -
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
by: Yasuo Takashima, et al.
Published: (2021-01-01) -
CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.
by: Yasuo Takashima, et al.
Published: (2019-01-01) -
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells
by: Yasuo Takashima, et al.
Published: (2019-09-01)